Canagliflozin Hydrochloride (Canaglu), as a new-generation oral hypoglycemic agent, plays an important role in the treatment of type 2 diabetes mellitus.

How to Purchase Canagliflozin Hydrochloride (Canaglu)?

Overseas Purchase

Patients may consult and purchase canagliflozin hydrochloride from hospital pharmacies or licensed pharmacies in countries/regions where the medication is approved for marketing.

Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients should make adequate budgeting and planning before purchase.

Purchase through Medical Service Providers

Patients may consult domestic overseas medical service institutions that collaborate with international pharmacies or pharmaceutical companies.

These institutions typically offer legal import channels and provide professional consultation and guidance.

Precautions for Purchasing Canagliflozin Hydrochloride (Canaglu)

Pre-Medication Medical Evaluation Requirements

Renal Function Assessment: Renal function should be evaluated before use. The medication is not recommended for patients with an estimated glomerular filtration rate (eGFR) below 45 mL/min/1.73m².

Hepatic Function Monitoring: Caution should be exercised in patients with severe hepatic impairment.

Cardiovascular Status Assessment: Individualized assessment is required for patients at risk of cardiovascular diseases.

Special Population Medication Warnings

Contraindicated in pregnant and lactating women.

Not recommended for patients with type 1 diabetes mellitus.

The efficacy of the medication in children and adolescents has not been established.

Management of Drug Interactions

Concurrent use with diuretics, insulin, or sulfonylureas may increase the risk of hypoglycemia. Close monitoring of blood glucose and appropriate dosage adjustments are required.

Concurrent use with strong UGT inducers may reduce the efficacy of canagliflozin.

Authenticity Verification Methods for Canagliflozin Hydrochloride (Canaglu)

Outer Packaging Feature Identification

The outer packaging of genuine canagliflozin hydrochloride is clearly printed with bright colors, and contains complete information such as drug approval number, production batch number, and expiration date.

The packaging box is made of thick material with exquisite craftsmanship and no obvious defects.

Drug Characteristic Inspection

The tablets should be white or off-white film-coated tablets with clear identification codes printed on the surface.

The tablets are intact without damage, and free from mold, discoloration, deliquescence, or other abnormalities.

Anti-Counterfeiting Mark Verification

The drug source and circulation information can be verified by querying the drug traceability code on the website of the National Medical Products Administration (NMPA) or an officially designated drug traceability platform.

The query result of the traceability code for genuine drugs should be completely consistent with the physical product information.

Completeness of Purchase Vouchers

Complete sales vouchers, including purchase date, drug batch number, sales unit, and other information, will be provided for sales through legitimate channels.

Relevant documents should be properly kept after purchase for future rights protection purposes.